Cargando…
Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation
Despite recent innovation in treatment techniques and subsequently improved outcomes, the majority of glioblastoma (GBL) have relapses, especially in locoregional areas. Local re-irradiation (re-RT) has been established as a feasible option for recurrent GBL of all ages with safety, tolerability, an...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453809/ https://www.ncbi.nlm.nih.gov/pubmed/30947475 http://dx.doi.org/10.3857/roj.2019.00171 |